for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Avinger Inc

AVGR.OQ

Latest Trade

1.11USD

Change

0.20(+21.98%)

Volume

285,138

Today's Range

0.86

 - 

1.14

52 Week Range

0.77

 - 

12.60

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
0.91
Open
0.94
Volume
285,138
3M AVG Volume
8.38
Today's High
1.14
Today's Low
0.86
52 Week High
12.60
52 Week Low
0.77
Shares Out (MIL)
10.23
Market Cap (MIL)
11.36
Forward P/E
-0.66
Dividend (Yield %)
--

Latest Developments

More

Avinger Prices $4.5 Mln Underwritten Public Offering Of Common Stock

Avinger Announces Proposed Underwritten Public Offering Of Common Stock

Avinger Reports Second Quarter Loss Per Share Of $0.87

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Avinger Inc

Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The Company focuses on introducing products based on its lumivascular platform, which is an intravascular image-guided system. The Company manufactures and sells a suite of products in the United States and certain European markets. The Company's products include Lightbox imaging console, as well as its Wildcat, Kittycat and the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO). The lumivascular platform offers real-time visualization of the inside of the artery during PAD treatment. The lumivascular platform consists of a capital component Lightbox and a range of disposable catheter products, including Ocelot, Ocelot PIXL, Ocelot MVRX and Pantheris.

Industry

Medical Equipment & Supplies

Contact Info

400 Chesapeake Dr

+1.650.3632400

http://avinger.com/

Executive Leadership

James G. Cullen

Non-Executive Chairman of the Board

Jeffrey M. Soinski

President, Chief Executive Officer, Director

Mark Weinswig

Chief Financial Officer

Himanshu N. Patel

Chief Technology Officer

Jaafer Golzar

Chief Medical Officer

Key Stats

1.50 mean rating - 2 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

0.0K

2017

0.0K

2018

0.0K

2019(E)

0.0K
EPS (USD)

2016

-1,356.000

2017

-720.400

2018

-33.400

2019(E)

-1.685
Price To Earnings (TTM)
--
Price To Sales (TTM)
1.38
Price To Book (MRQ)
0.72
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
82.67
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
-199.44
Return on Equity (TTM)
-88.17

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up